KalVista Pharmaceuticals Net Profit Margin 2014-2019 | KALV

KalVista Pharmaceuticals net profit margin from 2014 to 2019. Net profit margin can be defined as net Income as a portion of total sales revenue.
KalVista Pharmaceuticals Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2019-07-31 $0.02B $-0.02B -143.75%
2019-04-30 $0.02B $-0.02B -123.53%
2019-01-31 $0.02B $-0.01B -68.42%
2018-10-31 $0.02B $-0.01B -82.35%
2018-07-31 $0.01B $-0.02B -133.33%
2018-04-30 $0.01B $-0.02B -200.00%
2018-01-31 $0.00B $-0.02B -450.00%
2017-10-31 $0.00B $-0.02B -1050.00%
2017-07-31 $0.00B $-0.02B -2000.00%
2017-04-30 $0.00B $-0.02B -1700.00%
2017-01-31 $0.00B $-0.02B -1800.00%
2016-10-31 $0.00B $-0.02B -1700.00%
2016-09-30 $0.00B $-0.01B -366.67%
2016-07-31 $0.00B $-0.02B -533.33%
2016-06-30 $0.00B $-0.02B -750.00%
2016-04-30 $0.00B $-0.02B -1000.00%
2016-03-31 $0.00B $-0.03B inf%
2016-01-31 $0.00B $-0.03B inf%
2015-12-31 $0.00B $-0.02B -1100.00%
2015-09-30 $0.00B $-0.02B -750.00%
2015-06-30 $0.00B $-0.02B -750.00%
2015-01-31 $0.00B $-0.01B inf%
2014-06-30 $0.00B $-0.01B inf%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.200B $0.016B
KalVista Pharmaceuticals, Inc. is a pharmaceuticals company. It engages in discovery, development and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product portfolio consist hereditary angioedema and diabetic macular edema, KVD818 and KVD001, which are in clinical stage. KalVista Pharmaceuticals, Inc., formerly known as Carbylan Therapeutics, Inc., is headquartered in Cambridge, United States.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $61.158B 9.66
Zoetis (ZTS) United States $55.822B 33.39
Astellas Pharma (ALPMY) Japan $32.413B 15.44
Eisai (ESALY) Japan $19.472B 37.55
Merck (MKGAF) Germany $15.591B 21.27
Grifols, S.A (GRFS) Spain $14.693B 18.75
UCB SA (UCBJF) Belgium $14.669B 0.00
Neurocrine Biosciences (NBIX) United States $10.259B 484.35
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $9.028B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Ionis Pharmaceuticals (IONS) United States $8.015B 16.23
Jazz Pharmaceuticals (JAZZ) Ireland $7.486B 9.56
Sage Therapeutics (SAGE) United States $7.312B 0.00
Catalent (CTLT) United States $7.236B 29.44
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.214B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.267B 18.93
Arrowhead Pharmaceuticals (ARWR) United States $4.293B 98.42
United Therapeutics (UTHR) United States $3.930B 0.00
Nektar Therapeutics (NKTR) United States $3.579B 0.00
Evotec AG (EVTCY) Germany $3.212B 52.56
FibroGen (FGEN) United States $3.091B 91.18
Taro Pharmaceutical Industries (TARO) Israel $2.934B 10.72
PTC Therapeutics (PTCT) United States $2.574B 0.00
Portola Pharmaceuticals (PTLA) United States $2.154B 0.00
Tilray (TLRY) Canada $2.106B 0.00
Xencor (XNCR) United States $1.972B 59.94
Zogenix (ZGNX) United States $1.963B 0.00
Corcept Therapeutics (CORT) United States $1.841B 22.38
Pacira Pharmaceuticals (PCRX) United States $1.788B 52.89
Ironwood Pharmaceuticals (IRWD) United States $1.780B 56.75
Heron Therapeutics (HRTX) United States $1.655B 0.00
USANA Health Sciences (USNA) United States $1.610B 17.18
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.212B 19.99
Radius Health (RDUS) United States $1.161B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.977B 0.00
Karyopharm Therapeutics (KPTI) United States $0.969B 0.00
ArQule (ARQL) United States $0.953B 0.00
Endo (ENDP) Ireland $0.938B 1.72
Spectrum Pharmaceuticals (SPPI) United States $0.915B 0.00
Aerie Pharmaceuticals (AERI) United States $0.875B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.808B 5.51
TherapeuticsMD (TXMD) United States $0.740B 0.00
Organogenesis Holdings (ORGO) United States $0.711B 0.00
Collegium Pharmaceutical (COLL) United States $0.642B 0.00
Flexion Therapeutics (FLXN) United States $0.609B 0.00
Translate Bio (TBIO) United States $0.565B 0.00
ChemoCentryx (CCXI) United States $0.559B 0.00
Concordia (CXRXF) Canada $0.552B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.506B 61.38
ImmunoGen (IMGN) United States $0.482B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.472B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.458B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.454B 0.00
Dermira (DERM) United States $0.441B 0.00
Siga Technologies (SIGA) United States $0.412B 9.41
Akebia Therapeutics (AKBA) United States $0.396B 0.00
Indivior (INVVY) United States $0.390B 1.41
DURECT (DRRX) United States $0.385B 0.00
OptiNose (OPTN) United States $0.383B 0.00
Recro Pharma (REPH) United States $0.383B 0.00
Ardelyx (ARDX) United States $0.381B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.380B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.374B 16.14
Innate Pharma SA (IPHYF) France $0.372B 0.00
Lannett Co Inc (LCI) United States $0.362B 4.22
Harpoon Therapeutics (HARP) United States $0.324B 0.00
Molecular Templates (MTEM) United States $0.323B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.282B 0.00
GlycoMimetics (GLYC) United States $0.258B 0.00
Rafael Holdings (RFL) United States $0.244B 0.00
Xeris Pharmaceuticals (XERS) United States $0.221B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.208B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.198B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.187B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.182B 0.00
Nature's Sunshine Products (NATR) United States $0.181B 31.23
MARKER THERAPEUTICS, INC (MRKR) United States $0.179B 0.00
Concert Pharmaceuticals (CNCE) United States $0.176B 0.00
Calithera Biosciences (CALA) United States $0.167B 0.00
Jounce Therapeutics (JNCE) United States $0.164B 2.19
Taiwan Liposome (TLC) Taiwan $0.163B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.153B 0.00
CV Sciences (CVSI) United States $0.152B 0.00
Aquestive Therapeutics (AQST) United States $0.144B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.142B 0.00
CannTrust Holdings (CTST) Canada $0.139B 0.00
MEI Pharma (MEIP) United States $0.138B 0.00
Redhill Biopharma (RDHL) Israel $0.134B 0.00
IMV INC (IMV) Canada $0.131B 0.00
Ocular Therapeutix (OCUL) United States $0.121B 0.00
Cardiome Pharma (CORV) Canada $0.119B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.096B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.089B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 25.77
Neos Therapeutics (NEOS) United States $0.079B 0.00
Majesco Entertainment (PTE) United States $0.078B 0.00
MediWound (MDWD) Israel $0.078B 0.00
Otonomy (OTIC) United States $0.077B 0.00
Aclaris Therapeutics (ACRS) United States $0.075B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.073B 0.00
Generex Biotechnology (GNBT) United States $0.069B 0.00
SCYNEXIS (SCYX) United States $0.067B 0.00
Champions Oncology (CSBR) United States $0.065B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.063B 0.00
Natural Alternatives (NAII) United States $0.063B 9.55
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.059B 0.00
Medicure (MCUJF) Canada $0.058B 0.00
Novan (NOVN) United States $0.057B 0.00
Genocea Biosciences (GNCA) United States $0.056B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.056B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
RENEURON GP (RNUGF) United Kingdom $0.054B 0.00
IntelGenx Technologies (IGXT) Canada $0.054B 0.00
AgeX Therapeutics (AGE) United States $0.054B 0.00
ElectroCore (ECOR) United States $0.054B 0.00
Infinity Pharmaceuticals (INFI) United States $0.052B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.048B 0.00
Jaguar Animal Health (JAGX) United States $0.046B 0.00
Nivalis Therapeutics (ALPN) United States $0.045B 0.00
Capnia (SLNO) United States $0.045B 0.00
CTI BioPharma (CTIC) United States $0.044B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.042B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.037B 0.00
Opexa Therapeutics (ACER) United States $0.034B 0.00
India Globalization Capital (IGC) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.034B 0.00
Mast Therapeutics (SVRA) United States $0.032B 0.00
Bio-Path Holdings (BPTH) United States $0.031B 0.00
Biomerica (BMRA) United States $0.030B 0.00
Melinta Therapeutics (MLNT) United States $0.028B 0.00
PharmAthene (ALT) United States $0.027B 0.00
China SXT Pharmaceuticals (SXTC) China $0.025B 0.00
IsoRay (ISR) United States $0.023B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Lipocine (LPCN) United States $0.020B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.016B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Heat Biologics (HTBX) United States $0.014B 0.00
Shineco (TYHT) China $0.014B 17.17
Regulus Therapeutics (RGLS) United States $0.014B 0.00
HANCOCK JAFFE (HJLI) United States $0.011B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Achieve Life Sciences (ACHV) United States $0.008B 0.00
RXi Pharmaceuticals (PHIO) United States $0.007B 0.00
Vical (BBI) United States $0.007B 0.00
VAXART, INC (VXRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Midatech Pharma (MTP) United Kingdom $0.003B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Hemispherx BioPharma (AIM) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00